Drug Trial Radar · NCT02185417
Diuretic Comparison Project
Last checked: Nov 19, 2026Latest source record: May 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,723
Actual
Start
Jun 15, 2016
Primary completion
Oct 15, 2022
Study completion Dec 29, 2022
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Jul 9, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Diuretic Comparison Project aimed to evaluate whether chlorthalidone, as compared with hydrochlorothiazide, would reduce the risk of major nonfatal cardiovascular disease outcomes and non-cancer-related deaths in older patients with hypertension who were receiving hydrochlorothiazide at baseline. The investigators incorporated the pragmatic methods used by the Department of Veterans Affairs (VA) Healthcare System to provide a real-world assessment of the effectiveness of chlorthalidone as compared with hydrochlorothiazide in routine clinical care.
Conditions
- Hypertension
Interventions
Hydrochlorothiazide (HCTZ)Drug
Trial activities following study randomization were considered as usual care. Prescriptions of the allocated drug were managed by the primary care providers and patients would receive the prescribed mediations through the VA outpatient pharmacy services.
Chlorthalidone (CTD)Drug
Trial activities following study randomization were considered as usual care. Prescriptions of the allocated drug were managed by the primary care providers and patients would receive the prescribed mediations through the VA outpatient pharmacy services.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time From Randomization to Composite Primary OutcomeTime frame: Outcome data collection was performed from study randomization until the participants deceased, withdrawn, or reached end of study (Up to 5.4 years for the first patient enrolled and an average of 2.4 years for all participants).
- Proportion of Participants Had a Composite Primary OutcomeTime frame: Outcome data collection was performed from study randomization until the participants deceased, withdrawn, or reached end of study (Up to 5.4 years for the first patient enrolled and an average of 2.4 years for all participants).
Locations
70 sites in 2 countries. Site status is shown where the registry gives one.
Birmingham VA Medical Center, Birmingham, AL
Birmingham, Alabama
Alaska VA Healthcare System, Anchorage, AK
Anchorage, Alaska
Veterans Health Care System of the Ozarks, Fayetteville, AR
Fayetteville, Arkansas
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
Little Rock, Arkansas
VA Central California Health Care System, Fresno, CA
Fresno, California
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado
Grand Junction VA Medical Center, Grand Junction, CO
Grand Junction, Colorado
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut
Wilmington VA Medical Center, Wilmington, DE
Wilmington, Delaware
Washington DC VA Medical Center, Washington, DC
Washington D.C., District of Columbia
Bay Pines VA Healthcare System, Pay Pines, FL
Bay Pines, Florida
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida
VA Pacific Islands Health Care System, Honolulu, HI
Honolulu, Hawaii
Boise VA Medical Center, Boise, ID
Boise, Idaho
VA Illiana Health Care System, Danville, IL
Danville, Illinois
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois
Captain James A. Lovell Federal Health Care Center, North Chicago, IL
North Chicago, Illinois
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana
VA Central Iowa Health Care System, Des Moines, IA
Des Moines, Iowa
Iowa City VA Health Care System, Iowa City, IA
Iowa City, Iowa
Maine VA Medical Center, Augusta, ME
Togus, Maine
Rehabilitation R&D Service, Baltimore, MD
Baltimore, Maryland
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
Bedford, Massachusetts
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts
Aleda E. Lutz VA Medical Center, Saginaw, MI
Saginaw, Michigan
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota
St. Cloud VA Health Care System, St. Cloud, MN
Saint Cloud, Minnesota
VA Gulf Coast Veterans Health Care System, Biloxi, MS
Biloxi, Mississippi
Kansas City VA Medical Center, Kansas City, MO
Kansas City, Missouri
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
St Louis, Missouri
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska
Manchester VA Medical Center, Manchester, NH
Manchester, New Hampshire
New Mexico VA Health Care System, Albuquerque, NM
Albuquerque, New Mexico
Albany VA Medical Center Samuel S. Stratton, Albany, NY
Albany, New York
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
New York, New York
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.